Article Information
History
- October 2, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Denis Nash1,2,*,
- Avantika Srivastava1,2,
- Jenny Shen1,2,
- Kate Penrose1,
- Sarah Gorrell Kulkarni1,
- Rebecca Zimba1,2,
- William You1,
- Amanda Berry1,
- Chloe Mirzayi1,2,
- Andrew Maroko1,3,
- Angela M. Parcesepe1,4,5,
- Christian Grov1,6 and
- McKaylee M. Robertson1
- 1Institute for Implementation Science in Population Health (ISPH), City University of New York (CUNY); New York, New York, USA
- 2Department of Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York, New York, USA
- 3Department of Environmental, Occupational, and Geospatial Health Sciences, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York, New York, USA
- 4Department of Maternal and Child Health, Gillings School of Public Health, University of North Carolina, Chapel Hill, North Carolina, USA
- 5Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
- 6Department of Community Health and Social Sciences, Graduate School of Public Health and Health Policy, City University of New York (CUNY); New York, New York, USA
- ↵*CORRESPONDING AUTHOR: Denis Nash, Ph.D., MPH CUNY Graduate School of Public Health and Health Policy 55 W. 125th St., 6th Floor, New York, NY USA 10027 Phone: +1-917-740-8714, Fax: +1-866-792-7203, Email: denis.nash{at}sph.cuny.edu
Posted October 02, 2023.
Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults
